The federal contract award SPE2DB24D1104|SPE2DB25FXUD2, valued at $2,595.17, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide the medication Quillivant XR 25 mg/5 ml suspension, 180 ml. This is a delivery order contract with a firm fixed price and an ultimate completion date of November 5, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisitions, and technical services to the U.S. military. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award does not have a set-aside designation, indicating open competition.
Generated 2/3/25, 1:32 PM